We found that tumor‐infiltrating Siglecg−/− CD8+ T cells expressed lower levels of inhibitory markers such as PD‐1 and Tim‐3 (Figure 5B) and exhibited increased IFN‐γ production compared to their WT counterparts (Figure 5C). This evidence concerns the gene PDCD1 and neoplasm.